NCT01688739: Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients
- State
- Completed
- Phase
- Phase 1
- People
- 61 taking part
- Started
- 13 Mar 2012
- Primary completion
- 27 Mar 2013
- Arms
- Erenumab
- Results
- Posted on the registry
- 13 Mar 2012: Trial started
- 20 Sep 2012: Trial registered
- 27 Mar 2013: Trial completed
- 18 Jan 2019: Trial results posted